New cancer clinical trial: Compassionate Use: Patient With Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib

Published on: December 29, 2017 at 10:00AM
Condition:   Progressive Metastatic Castrate Resistant Prostate Cancer
Intervention:   Drug: Trametinib 2 mg
Sponsors:   Jonsson Comprehensive Cancer Center;   Novartis
Available
http://ift.tt/2CbpOoN